worldwide in all races and ethnic groups. First described by Hebra and Kaposi in 1874 the disorder is characterised by marked photosensitivity and premature onset of all major types of skin cancer. It is characterised by inability of a cell to repair damage caused by UV leading to genetic instability and skin cancer. Usually found at very young age(1-2yrs). XP affects approximately one in 1,00,000 individuals worldwide. One in 250,000 persons in the United States and Europe. Six times more common in Japanese people than in any other groups. The products of seven of XPgenes (XP-A through G) are involved in the repair of ultraviolet-induced photoproducts in DNA by the process of nucleotide excision repair (NER)5. The XPC and XPE proteins are needed to recognise the photoproducts in DNA. XPB and XPD are part of a protein complex TFIIH, which opens up the structure of the DNA around the site of the photoproduct. XPA protein verifies that proteins are in the correct position and then the nucleases XPG and XPF cut the DNA on either side of the damage, so that the damaged section can be removed and replaced with intact DNA. Patients defective in the XPC or XPE genes do not, in general, have the extreme sunburn reactions or neurological abnormalities. Defects in the eighth XP gene do not affect NER . The DNA polymerases that normally replicate DNA cannot deal with damage in the DNA template and specialised polymerases have to be employed to get past the damage (translesion synthesis). For UV damage, the cell uses DNA polymerase η, encoded by the gene POLH and this gene is mutated in XP-V patients . Like XP-C and XP-E patients, XP-V patients rarely have extreme sunburn reactions or neurological problems. Autosomal recessive genetic disorder. Nucleotide excision repair(NER) enzymes are mutated. Reduced or eliminated number of NER enzymes. Metastatic malignant melanoma. Squamos cell carcinoma. In recessive disorders, the condition does not appear unless a person inherits the same defective gene for thesame trait from each parent. If an individual receives one normal gene and one genefor the disease, the person will be a carrier for the disease. The risk of transmitting the disease to the children of a couple, both of whom are carriers for a recessive disorder, is 25 percent. Fifty percent of their children risk being carriers of the disease. Severe sunburn. Development of many freckles at an early age. Rough-surfaced growths (solar keratoses), and skin cancers. Eyes that are painfully sensitive to the sun and may easily become irritated, bloodshot and clouded. Blistering or freckling on minimum sun exposure. Spider Veins Limited growth of hair on chest and legs. Scaly skin Dry skin Irregular dark spots on the skin Corneal ulcerations Before birth: Amniocentesis Chorionic villous sampling After birth: Severe sunburn after first exposure to the sunlight. Based on clinical findings and family history,skin, eye, and nervous system. By measuring the DNA repair factor from skin or blood sample. Cryotherapy Removal of heat from the body.
Fluorouracil Pyrimidine analogue used to treat cancer.
Reduced exposure to sun’s UV rays
Many patients die at an early age from skin cancers but if a person is diagnosed early, does not have severe neurological symptoms and takes all the precautionary measures to avoid exposure to UV light, they may survive beyond middle age.
Less than 40% of individuals with the disease survive
beyond age 20.
Some with less severe cases manage to live well up to 40